Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy
This study is not yet open for participant recruitment.
Verified October 2017 by NeuroVia, Inc.
First Posted: June 23, 2017
Last Update Posted: October 18, 2017
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is not yet open for participant recruitment.|
|Estimated Study Completion Date:||December 1, 2020|
|Estimated Primary Completion Date:||December 1, 2020 (Final data collection date for primary outcome measure)|